Skip to main content

Table 2 Immuno- and cell-based therapy in pediatric oncology

From: Precision medicine in pediatric oncology

Disease Drug Target
1. Innate immunity
 1.1 osteosarcoma Mifamurtide NOD2
2. Humoral immunity
 2.1 Neuroblastoma Dinutuximab GD2
 2.2 NHL and PTLD Rituximab CD20
 2.3 HL and ALCL Brentuximab CD30
3. Cellular immunity
 3.1 AML DLI Multiple
 3.2 ALL CAR T-cells CD19
 3.3 Ewing sarcoma TCR T-cells CHM1